Skip to main content

Posts

Showing posts with the label Novel coronavirus

Nepal imposes ban on entry from 9 countries amid Omicron variant scare

  In a wake of global fear of new coronavirus variant Omicron, Nepal has decided to put a ban on nine countries including Hong Kong. In a wake of global fear of new coronavirus  variant Omicron , Nepal has decided to put a ban on nine countries including Hong Kong. A meeting of the council of ministers has decided to ban entry of passengers arriving from and transiting South Africa, Botswana, Zimbabwe, Namibia, Lesotho, Eswatini, Mozambique, Malawi and Hong Kong. As per the officials, travellers who have been to any of these nine countries in past three weeks also will be restricted from entering the Himalayan Nation. “As per the order passed by the cabinet meeting earlier on Monday, new restrictions on arrival from those 9 nations has been imposed. It already has gone into effect from Friday early morning. All the concerned authorities have been duly informed,” Phadindramani Pokhrel, spokesperson at the Ministry of Home Affairs confirmed to ANI over phone…. Read More

Blood clot risk much higher from Covid-19 than after vaccination: Study

  The risk of blood clots is higher after infection with the SARS-CoV-2 virus than after immunisation with Pfizer and AstraZeneca Covid-19 vaccines, according to a study The risk of developing adverse events such as blood clots is considerably higher after infection with the SARS-CoV-2 virus than after immunisation with Pfizer and AstraZeneca COVID-19 vaccines, according to a large UK study published in the British Medical Journal (BMJ) on Friday. The team led by researchers at the University of Oxford in the UK conducted the study on thrombocytopenia — a condition with low platelet counts — and thromboembolic events or blood clots following COVID-19 vaccination with  Oxford-AstraZeneca  and Pfizer-BioNTech preventives. Some of these events have led to restricted use of the Oxford-AstraZeneca vaccine, known as Covishield in India, in a number of countries. The researchers compared rates of adverse events after vaccination with rates of the same events after a positive SAR...